Dr Christopher Rentsch
Christopher received his MPH in Global Epidemiology from Emory University in 2011 and his PhD in Epidemiology & Population Health from LSHTM in 2018.
He was also awarded a Postgraduate Diploma in Advanced Quantitative Research Methods with Distinction from LSHTM in 2017.
Christopher is a co-organiser for the Practical Pharmacoepidemiology short course at LSHTM. He also teaches Advanced Statistical Methods in Epidemiology as a distance learning tutor.
At Emory University School of Medicine, he developed and led practicals for a short course on an introduction to epidemiology and biostatistics. He has also guest lectured on methods in HIV epidemiology and SAS programming at the Rollins School of Public Health.
As an active member of EHR Research Groups at LSHTM and Yale University, Christopher performs methodological and applied pharmacoepidemiological research using some of the largest EHR-based clinical and genetic cohorts in the world today.
In his current role at LSHTM, Christopher is harnessing UK Biobank and eHealth linkage to quantify risks, explore mechanisms, and determine treatment impacts between glycaemia and chronic disease across the full glycaemic spectrum.
At Yale, Christopher leads numerous investigations using multiple cohorts based on EHR and genetic data in the Veterans Health Administration, including the Million Veteran Program, Veteran Birth Cohort, and Veterans Aging Cohort Study. He is co-Chair and epidemiologic lead of the Polypharmacy and Antiviral Working Groups.